Recursion Pharmaceuticals, Inc.

IQ EQ FUND MANAGEMENT (IRELAND) Ltd RXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

2,404,118

Value ($000)

9,833

Weight

0.7%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	9,833	0.7%	2,404,118	12/31/2025
2025 Q3	11/5/2025	8,662	0.6%	1,774,995	9/30/2025
2025 Q2	8/1/2025	4,610	0.4%	911,085	6/30/2025